Q1 2021 Earnings

Investor Relations

Press Releases

29 Apr '21
First quarter GAAP EPS of $0.06 ; non-GAAP diluted EPS of $0.19 First quarter bookings of $194 million up 6% from the first quarter of 2020 Generated $56 million of cash flow from continuing operations and $35 million of free cash flow in the first quarter CHICAGO --(BUSINESS WIRE)--Apr.
19 Apr '21
CHICAGO --(BUSINESS WIRE)--Apr. 19, 2021-- Allscripts Healthcare Solutions, Inc . (Nasdaq:MDRX) will report its financial results for the three months ended March 31, 2021 after the close of stock market hours on Thursday, April 29, 2021 . Allscripts management plans to host a conference call and
05 Apr '21
Management services organization   partners with Allscripts to offer robust financial and scheduling platform to its clinics CHICAGO --(BUSINESS WIRE)--Apr. 5, 2021-- Allscripts Healthcare, LLC (Nasdaq:MDRX) announced today that it has partnered with Revo Health, LLC ( Revo ) to provide Allscripts

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Contact Investor Relations

Stephen Shulstein
Vice President, Investor Relations
Stephen.Shulstein@allscripts.com